pyrazole has been researched along with mocetinostat in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Axford, L; Cohick, E; Dales, N; Deng, L; Hamann, LG; Harrison, TJ; Hollis-Symynkywicz, M; Kecman, S; Lee, L; Loi, S; Marcinkeviciene, J; Marro, ML; Papillon, JPN; Patnaik, A; Patterson, AW; Regard, JB; Ren, X | 1 |
| Duclos, FJ; Duke, GJ; Halpern, OS; Hu, CH; Jusuf, S; Khan, JA; Kick, EK; Liu, X; Locke, GA; Neissel Valente, MW; Smallheer, JM; Wexler, RR | 1 |
2 other study(ies) available for pyrazole and mocetinostat
| Article | Year |
|---|---|
Discovery of a novel indole pharmacophore for the irreversible inhibition of myeloperoxidase (MPO).
Topics: Animals; Enzyme Inhibitors; Half-Life; Indoles; Mice; Peritonitis; Peroxidase; Pyrazoles; Structure-Activity Relationship | 2020 |
Small molecule and macrocyclic pyrazole derived inhibitors of myeloperoxidase (MPO).
Topics: Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Macrocyclic Compounds; Molecular Structure; Peroxidase; Pyrazoles; Small Molecule Libraries; Structure-Activity Relationship | 2021 |